91 – 100 of 381
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Gemtuzumab ozogamicin as postconsolidation therapy does not prevent relapse in children with AML: results from NOPHO-AML 2004
(
- Contribution to journal › Article
-
Mark
Emergence of NK cell progenitors and functionally competent NK cell lineage subsets in the early mouse embryo.
(
- Contribution to journal › Article
-
Mark
Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies
(
- Contribution to journal › Article
-
Mark
F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis
(
- Contribution to journal › Scientific review
-
Mark
Monocytic AML cells inactivate antileukemic lymphocytes: role of NADPH oxidase/gp91(phox) expression and the PARP-1/PAR pathway of apoptosis
(
- Contribution to journal › Article
-
Mark
Second malignancies after multiple myeloma: from 1960s to 2010s
(
- Contribution to journal › Scientific review
-
Mark
DNGR-1 is a specific and universal marker of mouse and human Batf3-dependent dendritic cells in lymphoid and nonlymphoid tissues
(
- Contribution to journal › Article
-
Mark
HemaExplorer: a Web server for easy and fast visualization of gene expression in normal and malignant hematopoiesis
(
- Contribution to journal › Letter
-
Mark
Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)
(
- Contribution to journal › Article
-
Mark
High ERG gene expression is an unfavorable prognostic marker in pediatric acute myeloid leukemia Response
(
- Contribution to journal › Letter